Previous Article | Next Article ![]()
Journal of Virology, April 2000, p. 3105-3111, Vol. 74, No. 7
Departments of Microbiology and Immunology
and Medicine, UCLA School of Medicine and Jonsson Comprehensive Cancer
Center, Los Angeles, California 90095
Received 7 May 1999/Accepted 7 January 2000
Human immunodeficiency virus type 1 (HIV-1) Vpr is a 96-amino-acid
protein that is found associated with the HIV-1 virion. Vpr induces
cell cycle arrest at the G2/M phase of the cell cycle, and
this arrest is followed by apoptosis. We examined the mechanism of
Vpr-induced apoptosis and found that HIV-1 Vpr-induced apoptosis requires the activation of a number of cellular cysteinyl
aspartate-specific proteases (caspases). We demonstrate that ectopic
expression of anti-apoptotic viral proteins, which inhibit caspase
activity, and addition of synthetic peptides, which represent caspase
cleavage sites, can inhibit Vpr-induced apoptosis. Finally, inhibition of caspase activity and subsequent inhibition of apoptosis results in
increased viral expression, suggesting that therapeutic strategies aimed at reducing Vpr-induced apoptosis in vivo require careful consideration.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Human Immunodeficiency Virus Type 1 Vpr Induces
Apoptosis through Caspase Activation

*
Corresponding author. Mailing address: Departments of
Microbiology & Immunology and Medicine, UCLA School of Medicine and Jonsson Comprehensive Cancer Center, 11-934 Louis Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1678. Phone: (310) 825-4793. Fax:
(310) 794-7682. E-mail: rtaweesu{at}ucla.edu.
Present address: Whitehead Institute for Biomedical Research,
Cambridge, MA 02142.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|